Avoid those 6 common mistakes and file a successful Marketing Authorization with the EMA.

Get 25 years of expert advice in this White Paper

A practical guide for first-time biopharma applicants entering the EU market.

Filing for EMA marketing authorisation is complex-especially for companies navigating it for the first time. This guide explores six frequent missteps that can delay or jeopardize approval.

What you’ll learn:

• Why early engagement with EMA and local agencies is non-negotiable
• How misunderstanding centralized procedures can derail timelines
• What a complete, high-quality dossier should look like
• The benefits of early Orphan/PRIME designation
• Why planning for realistic timelines and PIP compliance is essential

Each section includes real-world examples, EMA references, and practical tips to help regulatory and strategic teams improve their chances of a smooth, successful submission.